Chemical Compound

Butanoic acid, 2-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, (2S,3S)-; Butanoic acid, 2-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, [S-[R*,R*-(Z)]]-; Butanoic acid, 2-[[(2Z)-(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, (2S,3S)- (9CI); SQ 26992; Open Ring Aztreonam (USP)

CAS Registry Number 87500-74-1
返回搜索 申请报价
Butanoic acid, 2-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, (2S,3S)-; Butanoic acid, 2-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, [S-[R*,R*-(Z)]]-; Butanoic acid, 2-[[(2Z)-(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, (2S,3S)- (9CI); SQ 26992; Open Ring Aztreonam (USP) 结构式
Primary record

Butanoic acid, 2-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, (2S,3S)-; Butanoic acid, 2-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, [S-[R*,R*-(Z)]]-; Butanoic acid, 2-[[(2Z)-(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, (2S,3S)- (9CI); SQ 26992; Open Ring Aztreonam (USP)

库存
9,433 克
纯度
98.1 %
CAS
87500-74-1

化合物标识与属性

CAS
87500-74-1
PubChem CID
9576950
SMILES
C[C@@H]([C@@H](C(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C1=CSC(=N1)N)NS(=O)(=O)O
Canonical SMILES
C[C@H](NS(=O)(=O)O)[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c1csc(N)n1)C(=O)O

名称与同义词

  • Open Ring Aztreonam
  • Aztreonam Impurity A
  • UNII-7O397SYG7R
  • 87500-74-1
  • OPEN-RING AZTREONAM
  • SQ 26992
  • RefChem:185098
  • 7O397SYG7R
  • CHEBI:62665
  • Epitope ID:150789
  • sq-26992
  • Aztreonam Open Ring impurity
  • C13H19N5O9S2
  • SQ 26,992
  • SQ-26,992
  • MFCD28143136
  • OPEN RING AZTREONAM [USP-RS]
  • C13-H19-N5-O9-S2
  • CID9576950
  • SQ26992
  • DB-257615
  • G82569
  • Aztreonam Open-Ring Impurity(Aztreonam USP RC A)
  • Q27132071
  • (2S,3S)-2-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-3-(sulfoamino)butanoic acid
  • (2S,3S)-2-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)butanoic Acid
  • B2694-467190
  • (2S,3S)-2-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(sulfoamino)butanoic acid
  • Butanoic acid, 2-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-3-(sulfoamino)-, (S-(R*,R*-(Z)))-
  • 2-[[(2-amino-1,3-thiazol-4-yl)-[[(1S,2S)-1-carboxy-2-(sulfoamino)propyl]carbamoyl]methylidene]amino]oxy-2-methyl-propanoic acid
  • (2S,3S)-2-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetyl)amino)-3-(sulfoamino)butanoic acid
  • (2S,3S)-2-((Z)-2-(2-aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-3-(sulfoamino)butanoic acid
  • (2S,3S)-2-((Z)-2-(2-AMINOTHIAZOL-4-YL)-2-(2-CARBOXYPROPAN-2-YLOXYIMINO)ACETAMIDO(-3-(SULFOAMINO)BUTANOIC ACID
  • (2S,3S)-2-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-3-(sulfoamino)butanoic acid
  • 2-({[(1z)-1-(2-Amino-1,3-Thiazol-4-Yl)-2-Oxo-2-{[(2s,3s)-1-Oxo-3-(Sulfoamino)butan-2-Yl]amino}ethylidene]amino}oxy)-2-Methylpropanoic Acid
  • AZR
  • BUTANOIC ACID, 2-(((2Z)-(2-AMINO-4-THIAZOLYL)((1-CARBOXY-1-METHYLETHOXY)IMINO)ACETYL)AMINO)-3-(SULFOAMINO)-, (2S,3S)-
  • BUTANOIC ACID, 2-(((2Z)-2-(2-AMINO-4-THIAZOLYL)-2-((1-CARBOXY-1-METHYLETHOXY)IMINO)ACETYL)AMINO)-3-(SULFOAMINO)-, (2S,3S)-
  • Butanoic acid, 2-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, (2S,3S)-; Butanoic acid, 2-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, [S-[R*,R*-(Z)]]-; Butanoic acid, 2-[[(2Z)-(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-, (2S,3S)- (9CI); SQ 26992; Open Ring Aztreonam (USP)